Harrow Inc (HROW): Next-Year EPS Estimate 831.82%
As of 2026-06-04, Harrow Inc (HROW) has a next-year EPS growth estimate of 831.82%.
On 2026-05-17, analyst consensus for HROW's next-year EPS growth shifted from 727.73% to 831.82% — a positive change of 104.09 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at 276.79%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 831.82%
- EPS growth this year
- 276.79%
- EPS next quarter (est)
- -$0.17
- Last price
- $34.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 831.82% | 276.79% | -$0.17 | $34.69 |
| 2026-06-03 | 831.82% | 276.79% | -$0.17 | $33.32 |
| 2026-06-02 | 831.82% | 276.79% | -$0.17 | $32.86 |
| 2026-06-01 | 831.82% | 276.79% | -$0.17 | $34.11 |
| 2026-05-31 | 831.82% | 276.79% | -$0.17 | $35.21 |
| 2026-05-28 | 831.82% | 276.79% | -$0.17 | $35.39 |
| 2026-05-27 | 831.82% | 276.79% | -$0.17 | $34.43 |
| 2026-05-26 | 831.82% | 276.79% | -$0.17 | $34.17 |
| 2026-05-25 | 831.82% | 276.79% | -$0.17 | $33.00 |
| 2026-05-24 | 831.82% | 276.79% | -$0.17 | $33.00 |
| 2026-05-21 | 831.82% | 276.79% | -$0.17 | $32.96 |
| 2026-05-20 | 831.82% | 276.79% | -$0.17 | $30.86 |
| 2026-05-19 | 831.82% | 276.79% | -$0.17 | $30.68 |
| 2026-05-18 | 831.82% | 276.79% | -$0.17 | $30.90 |
| 2026-05-17 | 831.82% | 276.79% | -$0.17 | $31.21 |
| 2026-05-14 | 727.73% | 313.39% | -$0.16 | $30.86 |
| 2026-05-13 | 732.04% | 313.39% | -$0.11 | $30.13 |
| 2026-05-12 | 457.03% | 436.61% | -$0.03 | $29.03 |
| 2026-05-11 | 457.03% | 436.61% | -$0.35 | $38.04 |
| 2026-05-10 | 457.03% | 436.61% | -$0.35 | $38.23 |
| 2026-05-07 | 457.03% | 436.61% | -$0.35 | $39.05 |
| 2026-05-06 | 457.03% | 436.61% | -$0.35 | $40.27 |
| 2026-05-05 | 457.03% | 436.61% | -$0.35 | $40.50 |
| 2026-05-04 | 457.03% | 436.61% | -$0.35 | $40.20 |
| 2026-05-03 | 457.03% | 436.61% | -$0.35 | $40.90 |
| 2026-04-30 | 457.03% | 436.61% | -$0.35 | $40.53 |
| 2026-04-29 | 457.03% | 436.61% | -$0.35 | $40.24 |
| 2026-04-28 | 457.03% | 436.61% | -$0.35 | $40.48 |
| 2026-04-27 | 457.03% | 436.61% | -$0.35 | $41.41 |
| 2026-04-26 | 457.03% | 436.61% | -$0.35 | $39.70 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Harrow Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Harrow Inc (HROW) has a next-year EPS growth estimate of 831.82%, based on analyst consensus.
When was the latest EPS estimate revision for HROW?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 727.73% to 831.82%.
What sector and industry does Harrow Inc belong to?▾
Harrow Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HROW appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Harrow Inc (HROW) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports